In this Issue:
Day/night closed-loop free-living glucose control in type 1 diabetes
Home closed-loop control is safe and effective
Glycaemic excursions with closed-loop insulin: adjunctive pramlintide and liraglutide
Personalized MPC vs. PID algorithms for artificial pancreata
Day/night hybrid closed-loop insulin in adolescents with type 1 diabetes
Neighbourhood walkability and changes in overweight/obesity and diabetes
Microvascular disease and CV event risk in type 2 diabetes
Type 2 diabetes risk in gestational diabetes
Life expectancy and disability in Australian diabetics
Inhibiting bile acid transport: glucose and lipid effects
Please login below to download this issue (PDF)